Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


LCT Appoints Paris Brooke As General Manager

10 March 2005, Australia:
LCT appoints Paris Brooke as General Manager

Living Cell Technologies (ASX: LCT) today announced the appointment of Ms Paris Brooke to the position of General Manager.

Ms Brooke is a highly qualified biotechnology executive who specialises in business positioning, strategic advice and stakeholder management of biotechnology companies.

Ms Brooke's role will be effective from 1 April and she will be based in Melbourne. Her immediate attention will focus on building the Australian corporate office of LCT and raising the awareness of LCT's technology to sufferers of diabetes, Huntington's disease and haemophilia.

Previous to this appointment, Ms Brooke held the position of Policy and Communication Manager at AusBiotech - Australia's Biotechnology Industry Organisation, where she drove federal industry advocacy programs to position the biotechnology industry.

"LCT is one of Australia's most promising biotechnology companies and I am excited to become involved in it," said Ms Brooke.

Mr David Collinson, Chief Executive Officer of LCT, commented, "The appointment of Paris begins a new phase of development for LCT. We are delighted to have attracted someone with Paris' experience, strong reputation and deep commitment to the Australian biotechnology industry.

This is another important accomplishment for LCT. Along with our announcement of the cashless acquisition of Theracyte and Baxter's R&D worth an estimated US$90 million last week, and the successful preliminary results for DiaBCell last month, we are now poised for a momentum of activity," he added.

Ms Brooke has also been instrumental in the biotechnology sector through her management of businesses including SDA Biotech, a life science communications group, and BioNetwork, the first national magazine dedicated to biotechnology.

About LCT:

LCT is an ASX listed biotechnology company (ASX: LCT). Living Cell Technologies Ltd (LCT) began its business to develop and commercialise cell therapies for the treatment of a wide variety of diseases in 1987. The company has operating companies in New Zealand and Rhode Island, US.

LCT's technology has potential application for the treatment of conditions caused by a deficiency of specific cell function. The company has three products under development - NeurotrophinCell for Huntington's, Fac8Cell for haemophilia and DiaBCell for diabetes.


© Scoop Media

Business Headlines | Sci-Tech Headlines


ScoopPro: Helping The Education Sector Get More Out Of Scoop

The ScoopPro professional license includes a suite of useful information tools for professional users of Scoop including some specifically for those in the education sector to make your Scoop experience better. More>>

Big Tax Bill Due: Destiny Church Charities Deregistered

The independent Charities Registration Board has decided to remove Destiny International Trust and Te Hahi o Nga Matamua Holdings Limited from the Charities Register on 20 December 2017 because of the charities’ persistent failure to meet their annual return obligations. More>>

57 Million Users' Data: Uber Breach "Utterly Preventatable"

Cybersecurity leader Centrify says the Uber data breach of 57 million customer and driver records - which the ride-hailing company hid for more than a year - was “utterly preventable”. More>>

Scoop 3.0: How You Can Help Scoop’s Evolution

We have big plans for 2018 as we look to expand our public interest journalism coverage, upgrade our publishing infrastructure and offer even more valuable business tools to commercial users of Scoop. More>>

Having A Cow? Dairy Product Prices Slide For Fourth Straight Auction

Dairy product prices fell at the Global Dairy Trade auction, retreating for the fourth straight auction amid signs of increased production... Whole milk powder fell 2.7 percent to US$2,778 a tonne. More>>


Statistics: Butter At Record $5.67/Block; High Vegetable Prices

Rising dairy prices have pushed food prices up 2.7 percent in the year to October 2017, Stats NZ said today. This followed a 3.0 percent increase in the year to September 2017. More>>


Science: New Research Finds Herbicides Cause Antibiotic Resistance

New University of Canterbury research confirms that the active ingredients of the commonly used herbicides, RoundUp, Kamba and 2,4-D (glyphosate, dicamba and 2,4-D, respectively), each alone cause antibiotic resistance at concentrations well below label application rates. More>>


  • Bill Bennett on Tech